ArticleMedical oncology (Northwood, London, England)2025
BMP-9 promotes the expression of PD-L1 in osteosarcoma cells through FOXO1.
Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Osteosarcoma is the most common primary malignant bone tumor, and its occurrence and development are closely related to the bone microenvironment. Therefore, it is essential to understand the main factors that promote osteosarcoma progression in the bone microenvironment. Our study focused on the effect of BMP-9 on PD-L1 expression in osteosarcoma cells. The expression of PD-L1 was detected western blot and flow cytometry. Using RNA-seq analysis, we explored the mechanism that regulated PD-L1 mRNA expression. Our findings revealed that BMP-9 promoted PD-L1 protein expression in osteosarcoma cells. Further, BMP-9 induced the transcriptional expression of PD-L1 in osteosarcoma cells. RNA sequencing and TCGA database analysis showed that FOXO1 regulates the transcriptional expression of PD-L1. FOXO1 expression was significantly increased under BMP-9 action. Importantly, BMP-9 cannot increase the transcriptional and protein expression of PD-L1 in osteosarcoma cells when FOXO1 is knocked down. Additionally, the expression of BMP-9 was positively correlated with the expression of PD-L1 in clinical samples of osteosarcoma.
Indexed as
Identifiers
41160333What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.